Luoxin Pharmaceuticals Group Stock Balance Sheet Health
Financial Health criteria checks 1/6
Luoxin Pharmaceuticals Group Stock has a total shareholder equity of CN¥2.4B and total debt of CN¥1.9B, which brings its debt-to-equity ratio to 81%. Its total assets and total liabilities are CN¥5.3B and CN¥2.9B respectively.
Key information
81.0%
Debt to equity ratio
CN¥1.91b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥900.41m |
| Equity | CN¥2.35b |
| Total liabilities | CN¥2.90b |
| Total assets | CN¥5.25b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002793's short term assets (CN¥2.3B) do not cover its short term liabilities (CN¥2.6B).
Long Term Liabilities: 002793's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥330.2M).
Debt to Equity History and Analysis
Debt Level: 002793's net debt to equity ratio (42.7%) is considered high.
Reducing Debt: 002793's debt to equity ratio has increased from 19% to 81% over the past 5 years.
Debt Coverage: 002793's debt is not well covered by operating cash flow (9.9%).
Interest Coverage: Insufficient data to determine if 002793's interest payments on its debt are well covered by EBIT.